Neuroblastoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
In order to assess the neuronal-like properties of a human neuroblastoma cell line obtained by stable transfection of the estrogen receptor (SK-ER3) a series of quantitative measurements of the activity of two neurotransmitter-related enzymes: tyrosine hydroxylase (TH) and monamine oxidase (MAO), and of catecholamine concentrations were performed.
|
7903862 |
1993 |
Neuroblastoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The lack of model systems in which these phenomena could be studied prompted us to develop a neuroblastoma cell line expressing the estrogen receptor.
|
8475123 |
1993 |
Neuroblastoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The finding that, in neuroblastoma cells, selected signal transduction systems are involved in the insulin-dependent activation of estrogen receptor is of particular interest considering that estrogen receptor might restrict the role played by insulin during the differentiation of neural cells and interfere with its proliferative potential while allowing its regulation of other functions related to cell survival.
|
8732681 |
1996 |
Neuroblastoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
To evaluate the role of estrogen receptor in the differentiation of cells of neural origin, we developed a molecular approach aimed at the identification of estrogen target genes by mRNA differential display PCR (ddPCR) in human neuroblastoma SK-ER3 cells.
|
9169520 |
1997 |
Neuroblastoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Neurotransmitters activate the human estrogen receptor in a neuroblastoma cell line.
|
9328204 |
1997 |
Neuroblastoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Therefore, we analyzed the binding of [3H]-diprenorphine in human neuroblastoma cells stably transfected with the estrogen receptor cDNA (SK-ER3 cell line).
|
9892851 |
1999 |
Neuroblastoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways.
|
19476546 |
2009 |
Neuroblastoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
|
20080637 |
2010 |
Neuroblastoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Differential regulation of apoptosis-associated genes by estrogen receptor alpha in human neuroblastoma cells.
|
23271418 |
2013 |
Neuroblastoma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Estrogen receptor-mediated transcription involves the activation of multiple kinase pathways in neuroblastoma cells.
|
24121066 |
2014 |
Neuroblastoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.
|
26158518 |
2015 |
Neuroblastoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Transcription factor activity of estrogen receptor α activation upon nonylphenol or bisphenol A treatment enhances the in vitro proliferation, invasion, and migration of neuroblastoma cells.
|
27366082 |
2016 |
Neuroblastoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
E6-Associated Protein Dependent Estrogen Receptor Regulation of Protein Kinase A Regulatory Subunit R2A Expression in Neuroblastoma.
|
28214999 |
2018 |
Neuroblastoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Further examination revealed that infection with ERA-N273/394-G333 induces IFN-β and CXCL10 mRNA expressions more strongly than ERA-G333 infection in a neuroblastoma cell line.
|
28882441 |
2017 |
Neuroblastoma
|
0.400 |
PosttranslationalModification
|
disease |
BEFREE |
The purpose of our study was to investigate the effects of estrogen receptor (ER)-α36 gene silencing on tau protein phosphorylation, cell proliferation, and cell apoptosis in human neuroblastoma SH-SY5Y cells.
|
29932870 |
2018 |